VERACYTE, INC.

VCYT

Delayed - 01/15 04:00:01 pm
50.79USD	-3.40%

Turn to zoom

Prev.	52.5800
Open	52.4800
High	54.6400
Low	50.5400
Volume	679 914

01/06	Veracyte : to Participate in 23rd Annual Needham Virtual Growth Conference
12/30	Insider Trends: Veracyte Insider Exercises Options Extending 90-Day Buying Trend
12/22	Veracyte : Partners With Bayer for Thyroid Cancer Program; Shares Climb
12/22	Veracyte : Bayer and Veracyte Announce Precision Oncology Collaboration in...

	Short Term	Mid-Term	Long Term
Trend	Bearish	Bullish	Bullish
Resistance	54,9	61,9	57,6
Spread/Res.	-7,4%	-18%	-12%
Spread/Supp.	7,3%	19%	55%
Support	47,3	42,8	32,7

Sales 2020	115 M - -
Net income 2020	-33,4 M - -
Net cash 2020	335 M - -
P/E ratio 2020	-80,1x
Yield 2020	-

Capitalization	2 941 M 2 941 M -
EV / Sales 2020	22,7x
EV / Sales 2021	17,2x
Nbr of Employees	354
Free-Float	99,2%

Veracyte, Inc. is a genomic diagnostics company. The Company, through its scientific platform, which utilizes ribonucleic acid (RNA), whole-transcriptome sequencing combined with machine learning, produces genomic tests. It provides various genomic tests, including Afirma Genomic Sequencing...

>> Read more

Sector :

Bio Diagnostics & Testing

Calendar :

2021-03-02 Earnings Release

Trading Rating :

Investor Rating :

Mean consensus	OUTPERFORM
Number of Analysts	7
Average target price	46,20 $
Last Close Price	50,79 $
Spread / Highest target	18,1%
Spread / Average Target	-9,04%
Spread / Lowest Target	-31,1%